MEGF10 and neoplasm: A growing body of literature has documented the efficacy of CAR macrophages (CAR-mac) in targeting a diverse array of tumor types.29–32 Regarding the choice of the intracellular domain in the CAR construct, the majority of investigators have successfully utilized the CD3z30 MegF10, FcRγ31 or CD147 domains.